FOLD- Amicus Therapeutics, Inc.

Name: Amicus Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Campbell Bradley L	1.02M	$14.80M	-
Other	Rosenberg Ellen	464.6K	$6.73M	-
Other	Castelli Jeff	409.3K	$5.93M	-
Other	Clark David Michael	221.8K	$3.21M	-
CFO	Harford Simon N.R.	143.6K	$2.08M	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 20, 2023	Castelli Jeff67	Chief Development Officer	Sell	19,154	$13.24	$253,542.40	-2.6%	-7.8%	-24.2%
Dec 15, 2023	Crowley John F67	Executive Chairman	Sell	6,043	$12.66	$76,515.86	-0.7%	-9.3%	-26.4%
Dec 1, 2023	Campbell Bradley L66	President And CEO	Sale+OE	11,702	$11.08	$129,693.27	-1.5%	+14.3%	-11.1%
Dec 1, 2023	Crowley John F67	Executive Chairman	Sell	6,043	$11.08	$66,956.44	-0.7%	+14.3%	-11.1%
Nov 15, 2023	Crowley John F67	Executive Chairman	Sell	6,043	$10.84	$65,497.06	-0.7%	+20.1%	-5.3%
Nov 1, 2023	Campbell Bradley L66	President And CEO	Sale+OE	11,700	$10.97	$128,391.12	-1.5%	+15.2%	+4.0%
Nov 1, 2023	Crowley John F67	Executive Chairman	Sell	6,044	$10.97	$66,327.46	-0.7%	+15.2%	+4.0%
Oct 16, 2023	Crowley John F67	Executive Chairman	Sell	6,044	$10.50	$63,449.31	-0.7%	+20.5%	-2.4%
Oct 2, 2023	Crowley John F67	Executive Chairman	Sell	6,044	$11.25	$67,967.08	-0.3%	+29.1%	-3.4%
Oct 2, 2023	Campbell Bradley L66	President &CEO	Sale+OE	11,700	$11.24	$131,489.24	-0.7%	+29.1%	-3.4%

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC